GlobeNewswire Clinical StudiesOriginal article
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
Phase 1Sildenafil CreamPositive
AI Analysis
Summary
Daré Bioscience will present Phase 1 data on topical Sildenafil Cream at the SMSNA Annual Fall Scientific Meeting, comparing adverse events and bioavailability with oral sildenafil in healthy male adults.
Clinical Trial Data
Phase
Phase 1
Outcome Details
Phase 1 adverse event and relative bioavailability data comparing topical Sildenafil Cream with oral sildenafil in healthy male adults
Importance:4/10
Sentiment:
0.50
Phase 1 dataconference presentationtopical sildenafilbioavailability study
Read the original article
Published by GlobeNewswire Clinical Studies on October 8, 2026 1:15 PM